# Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers

> **NCT06176651** · PHASE4 · COMPLETED · sponsor: **Gordon Schanzlin New Vision** · enrollment: 49 (actual)

## Conditions studied

- Dry Eye
- Dry Eye, Evaporative
- Dry Eye Disease
- Evaporative Dry Eye
- Evaporative Dry Eye Disease
- Kerato Conjunctivitis Sicca

## Interventions

- **DRUG:** Miebo

## Key facts

- **NCT ID:** NCT06176651
- **Lead sponsor:** Gordon Schanzlin New Vision
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-21
- **Primary completion:** 2024-04-05
- **Final completion:** 2024-04-05
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06176651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06176651, "Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06176651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*